Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

MALVERN, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...